These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7317857)

  • 41. Protective activity of cholera vaccines against E1 Tor cholera vibrios.
    PITTMAN M; FEELEY JC
    Bull World Health Organ; 1963; 28(3):379-83. PubMed ID: 13943861
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Laboratory studies on the El Tor vibrio.
    SAYAMOV RM
    Bull World Health Organ; 1963; 28(3):311-25. PubMed ID: 13986981
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genomic relatedness of the new Matlab variants of Vibrio cholerae O1 to the classical and El Tor biotypes as determined by pulsed-field gel electrophoresis.
    Safa A; Bhuiyan NA; Alam M; Sack DA; Nair GB
    J Clin Microbiol; 2005 Mar; 43(3):1401-4. PubMed ID: 15750117
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization of a flagellar sheath protein of Vibrio cholerae.
    Hranitzky KW; Mulholland A; Larson AD; Eubanks ER; Hart LT
    Infect Immun; 1980 Feb; 27(2):597-603. PubMed ID: 7380541
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mode of action of bacteriophage phi 149 on cholera and El Tor vibrios.
    Maiti M
    Can J Microbiol; 1978 Dec; 24(12):1583-9. PubMed ID: 747818
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biotype-specific tcpA genes in Vibrio cholerae.
    Iredell JR; Manning PA
    FEMS Microbiol Lett; 1994 Aug; 121(1):47-54. PubMed ID: 7915998
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Diversity of lysogenic states among El Tor vibrios of various origins].
    Nicolle P; Gallut J; Schraen MF; Brault J
    Bull Soc Pathol Exot Filiales; 1971; 64(5):603-12. PubMed ID: 5172697
    [No Abstract]   [Full Text] [Related]  

  • 48. [Analysis of exoproteins of El Tor Vibrio cholerae by 2DE and MALDI-TOF-MS/MS].
    Yan X; Xiao D; Zhao F; Gu Y; Meng F; Zhang J
    Wei Sheng Wu Xue Bao; 2009 Jun; 49(6):746-58. PubMed ID: 19673410
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Value of phage typing of Vibrio cholerae biotype eltor in West Africa.
    Bockemühl J; Meinicke D
    Bull World Health Organ; 1976; 54(2):187-92. PubMed ID: 1088101
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Corresponding type-specificity of vibriocidal and agglutinating activities of Vibrio cholerae antisera: relevance to vaccine immunogenicity.
    Preston NW
    Epidemiol Infect; 1993 Jun; 110(3):489-97. PubMed ID: 8519314
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development of simple and rapid PCR-fingerprinting methods for Vibrio cholerae on the basis of genetic diversity of the superintegron.
    Chowdhury N; Asakura M; Neogi SB; Hinenoya A; Haldar S; Ramamurthy T; Sarkar BL; Faruque SM; Yamasaki S
    J Appl Microbiol; 2010 Jul; 109(1):304-12. PubMed ID: 20070445
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vibrio cholerae, Vibrio parahaemolyticus, and other vibrios: occurrence and distribution in Chesapeake Bay.
    Colwell RR; Kaper J; Joseph SW
    Science; 1977 Oct; 198(4315):394-6. PubMed ID: 910135
    [TBL] [Abstract][Full Text] [Related]  

  • 53. EFFECT OF MUKERJEE'S GROUP IV PHAGE ON EL TOR VIBRIOS.
    MONSUR KA; RIZVI SS; HUQ MI; BENENSON AS
    Bull World Health Organ; 1965; 32(2):211-6. PubMed ID: 14310908
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of Vibrio cholerae from 1986 to 2012 in Yunnan Province, southwest China bordering Myanmar.
    Gu W; Yin J; Yang J; Li C; Chen Y; Yin J; Xu W; Zhao S; Liang J; Jing H; Fu X
    Infect Genet Evol; 2014 Jan; 21():1-7. PubMed ID: 24177595
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nonlipopolysaccharide protective antigens shared by classical and El Tor biotypes of Vibrio cholerae.
    Sharma DP; Attridge S; Hackett J; Rowley D
    J Infect Dis; 1987 Apr; 155(4):716-23. PubMed ID: 3819476
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vibrio cholerae expresses iron-regulated outer membrane proteins in vivo.
    Sciortino CV; Finkelstein RA
    Infect Immun; 1983 Dec; 42(3):990-6. PubMed ID: 6642675
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Emergence of Vibrio cholerae O1 classical biotype in 2012 in Iran.
    Bakhshi B; Boustanshenas M; Mahmoudi-aznaveh A
    Lett Appl Microbiol; 2014 Feb; 58(2):145-9. PubMed ID: 24117836
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genome size and restriction fragment length polymorphism analysis of Vibrio cholerae strains belonging to different serovars and biotypes.
    Choudhury SR; Bhadra RK; Das J
    FEMS Microbiol Lett; 1994 Jan; 115(2-3):329-34. PubMed ID: 7908004
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Esterases and DNA base composition analysis of Vibrio cholerae and related vibrios.
    Colwell RR; Adeyemo VI; Kirtland HH
    J Appl Bacteriol; 1968 Sep; 31(3):323-35. PubMed ID: 5698667
    [No Abstract]   [Full Text] [Related]  

  • 60. [Differentiation of cholera and NAG vibrios by their virulence].
    Shashaev MA; Suleimenov BM; Evchenko IuM
    Zh Mikrobiol Epidemiol Immunobiol; 1980 Sep; (9):30-3. PubMed ID: 7004031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.